E
Estefanía Rodríguez
Researcher at Bernhard Nocht Institute for Tropical Medicine
Publications - 35
Citations - 1593
Estefanía Rodríguez is an academic researcher from Bernhard Nocht Institute for Tropical Medicine. The author has contributed to research in topics: Ebola virus & Virus. The author has an hindex of 17, co-authored 31 publications receiving 1057 citations. Previous affiliations of Estefanía Rodríguez include Icahn School of Medicine at Mount Sinai & Leibniz Association.
Papers
More filters
Journal ArticleDOI
Animal models for COVID-19.
César Muñoz-Fontela,William E. Dowling,Simon G. P. Funnell,Pierre Stéphane Gsell,A. Ximena Riveros-Balta,Randy A. Albrecht,Hanne Leth Andersen,Ralph S. Baric,Miles W. Carroll,Marco Cavaleri,Chuan Qin,Ian Crozier,Kai Dallmeier,Leon de Waal,Emmie de Wit,Leen Delang,Erik D. Dohm,W. Paul Duprex,Darryl Falzarano,Courtney L. Finch,Matthew B. Frieman,Barney S. Graham,Lisa E. Gralinski,Kate Guilfoyle,Bart L. Haagmans,Geraldine A. Hamilton,Amy L. Hartman,Sander Herfst,Suzanne J.F. Kaptein,William B. Klimstra,Ivana Knezevic,Philip R. Krause,Jens H. Kuhn,Roger Le Grand,Mark G. Lewis,Wen-Chun Liu,Pauline Maisonnasse,Anita K. McElroy,Vincent J. Munster,Nadia Oreshkova,Angela L. Rasmussen,Joana Rocha-Pereira,Barry Rockx,Estefanía Rodríguez,Thomas F. Rogers,Francisco J. Salguero,Michael Schotsaert,Koert J. Stittelaar,Hendrik Jan Thibaut,Chien Te K. Tseng,Júlia Vergara-Alert,Martin Beer,Trevor Brasel,Jasper Fuk-Woo Chan,Adolfo García-Sastre,Johan Neyts,Stanley Perlman,Douglas S. Reed,Juergen A. Richt,Chad J. Roy,Joaquim Segalés,Seshadri S. Vasan,Seshadri S. Vasan,Ana Maria Henao-Restrepo,Dan H. Barouch +64 more
TL;DR: The findings of a World Health Organization expert working group that is developing animal models to test vaccines and therapeutic agents for the treatment of COVID-19, and their relevance for preclinical testing, are reviewed.
Journal ArticleDOI
The sequential activation of the yeast HOG and SLT2 pathways is required for cell survival to cell wall stress.
Clara Bermejo,Estefanía Rodríguez,Raúl García,José Manuel Rodríguez-Peña,María Luisa Rodríguez de la Concepción,Carmen Rivas,Patricia Arias,César Nombela,Francesc Posas,Javier Arroyo +9 more
TL;DR: Both MAPK pathways are essential for cell survival under these circumstances because mutant strains deficient in different components of both pathways are hypersensitive to zymolyase.
Journal ArticleDOI
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.
Daouda Sissoko,Sophie Duraffour,Romy Kerber,Jacques Seraphin Kolié,Abdoul Habib Beavogui,Alseny Modet Camara,Géraldine Colin,Toni Rieger,Lisa Oestereich,Bernadett Pályi,Stephanie Wurr,Jeremie Guedj,Thi Huyen Tram Nguyen,Rosalind M Eggo,Conall H. Watson,W. John Edmunds,Joseph Akoi Bore,Fara Raymond Koundouno,Mar Cabeza-Cabrerizo,Lisa L. Carter,Liana E. Kafetzopoulou,Eeva Kuisma,Janine Michel,Livia Victoria Patrono,Natasha Y. Rickett,Katrin Singethan,Martin Rudolf,Angelika Lander,Elisa Pallasch,Sabrina Bockholt,Estefanía Rodríguez,Antonino Di Caro,Roman Wölfel,Martin Gabriel,Cèline Gurry,Pierre Formenty,Sakoba Keita,Denis Malvy,Miles W. Carroll,Miles W. Carroll,Xavier Anglaret,Stephan Günther +41 more
TL;DR: Using the biostatistical model, it is predicted that 50% and 90% of male survivors clear Ebola virus RNA from seminal fluid at 115 days (90% prediction interval 72-160) and 294 days (212-399) after disease onset, respectively, and the number of men positive for Ebola virusRNA in affected countries would decrease from about 50 in January 2016, to fewer than 1 person by July, 2016.
Journal ArticleDOI
A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response.
Analisa DiFeo,Lauren D. Feld,Estefanía Rodríguez,Christine Wang,David G. Beer,John A. Martignetti,Goutham Narla +6 more
TL;DR: It is shown that increased expression of KLF6-SV1 is associated with decreased survival in patients with lung adenocarcinoma, and targeted reduction of KLFsV1 using siRNA induces apoptosis both alone and in combination with the chemotherapeutic drug cisplatin.
Journal ArticleDOI
Innovations, challenges, and minimal information for standardization of humanized mice.
Renata Stripecke,Christian Münz,Jan Jacob Schuringa,Karl-Dimiter Bissig,Brian Soper,Terrence Meeham,Li-Chin Yao,James P. Di Santo,Michael A. Brehm,Estefanía Rodríguez,Anja Kathrin Wege,Dominique Bonnet,Silvia Guionaud,Kristina E. Howard,Scott G. Kitchen,Florian Klein,Kourosh Saeb-Parsy,Johannes Sam,Amar Deep Sharma,Andreas Trumpp,Livio Trusolino,Carol J. Bult,Leonard D. Shultz +22 more
TL;DR: An international community‐driven resource called “Minimal Information for Standardization of Humanized Mice” (MISHUM) has been created for the purpose of enhancing rigor and reproducibility of studies in the field.